Biological evaluation of pH-responsive polymer-caged nanobins for breast cancer therapy

ACS Nano

Volumn 4, Issue 9, 2010, Pages 4971-4978

  Lee, Sang Min ^a,b,d   Ahn, Richard W ^a,b,d   Chen, Feng ^b,c,d   Fought, Angela J ^d   Ohalloran, Thomas V ^a,b,d   Cryns, Vincent L ^b,c,d   Nguyen, Sonbinh T ^a,b,d  

^a Department of Chemistry ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Cell Death Regulation Laboratory   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

breast cancer; in vivo drug delivery; liposome; pH responsive release; polymers

Indexed keywords

ACIDIC ENVIRONMENT; BIOLOGICAL EVALUATION; BREAST CANCER; CANCER THERAPY; CROSS-LINKED POLYMERS; DOXORUBICIN; DRUG ENCAPSULATION; DRUG RELEASE; ENDOSOMES; IN-VIVO; MURINE MODEL; NANOCARRIERS; PH-RESPONSIVE; PH-RESPONSIVE POLYMER; PH-RESPONSIVE RELEASE; POTENTIAL UTILITY; SOLID TUMORS; TUMOR GROWTH;

DRUG DELIVERY; ENCAPSULATION; ONCOLOGY; TUMORS;

POLYMERS;

DOXORUBICIN; NANOCAPSULE; POLYMER;

ANIMAL; APOPTOSIS; ARTICLE; BREAST TUMOR; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; FEMALE; HELA CELL; HUMAN; MOUSE; NANOMEDICINE; PATHOLOGY; PH; SURFACE PROPERTY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOXORUBICIN; FEMALE; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; MICE; NANOCAPSULES; NANOMEDICINE; POLYMERS; SURFACE PROPERTIES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77957321135     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn100560p     Document Type: Article

References (40)

1. Allen, T. M.; Cullis, P. R. Drug Delivery Systems: Entering the Mainstream Science 2004, 303, 1818-1822
2. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760
3. Davis, M. E.; Chen, Z.; Shin, D. M. Nanoparticle Therapeutics: An Emerging Treatment Modality for Cancer Nat. Rev. Drug Discovery 2008, 7, 771-782
4. Drummond, D. C.; Meyer, O.; Hong, K.; Kirpotin, D. B.; Papahadjopoulos, D. Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors Pharmacol. Rev. 1999, 51, 691-744
5. Waterhouse, D. N.; Tardi, P. G.; Mayer, L. D.; Bally, M. B. A Comparison of Liposomal Formulations of Doxorubicin with Drug Administered in Free Form: Changing Toxicity Profiles Drug Saf. 2001, 24, 903-920
6. Gabizon, A.; Catane, R.; Uziely, B.; Kaufman, B.; Safra, T.; Cohen, R.; Martin, F.; Huang, A.; Barenholz, Y. Prolonged Circulation Time and Enhanced Accumulation in Malignant Exudates of Doxorubicin Encapsulated in Polyethylene-Glycol Coated Liposomes Cancer Res. 1994, 54, 987-992
7. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor Vascular Permeability and the EPR Effect in Macromolecular Therapeutics: A Review J. Controlled Release 2000, 65, 271-284
8. Bandak, S.; Goren, D.; Horowitz, A.; Tzemach, D.; Gabizon, A. Pharmacological Studies of Cisplatin Encapsulated in Long-Circulating Liposomes in Mouse Tumor Models Anti-Cancer Drugs 1999, 10, 911-920
9. Laginha, K. M.; Verwoert, S.; Charrois, G. J. R.; Allen, T. M. Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors Clin. Cancer Res. 2005, 11, 6944-6949
10. Rui, Y.; Wang, S.; Low, P. S.; Thompson, D. H. Diplasmenylcholine-Folate Liposomes: An Efficient Vehicle for Intracellular Drug Delivery J. Am. Chem. Soc. 1998, 120, 11213-11218
11. Connor, J.; Yatvin, M. B.; Huang, L. pH-Sensitive Liposomes: Acid-Induced Liposome Fusion Proc. Natl. Acad. Sci. U.S.A. 1984, 81, 1715-1718
12. Gerasimov, O. V.; Boomer, J. A.; Qualls, M. M.; Thompson, D. H. Cytosolic Drug Delivery Using pH- and Light-Sensitive Liposomes Adv. Drug Delivery Rev. 1999, 38, 317-338
13. Zalipsky, S.; Qazen, M.; Walker, J. A.; Mullah, N.; Quinn, Y. P.; Huang, S. K. New Detachable Poly(ethylene glycol) Conjugates: Cysteine-Cleavable Lipopolymers Regenerating Natural Phospholipid, Diacyl Phosphatidylethanolamine Bioconjugate Chem. 1999, 10, 703-707
14. Bergstrand, N.; Arfvidsson, M. C.; Kim, J.-M.; Thompson, D. H.; Edwards, K. Interactions between pH-Sensitive Liposomes and Model Membranes Biophys. Chem. 2003, 104, 361-379
15. Lee, S.-M.; Chen, H.; Dettmer, C. M.; OHalloran, T. V.; Nguyen, S. T. Polymer-Caged Liposomes: A pH-Responsive Delivery System with High Stability J. Am. Chem. Soc. 2007, 129, 15096-15097
16. Lee, S.-M.; Chen, H.; OHalloran, T. V.; Nguyen, S. T. 'Clickable Polymer-Caged Nanobins as a Modular Drug Delivery Platform J. Am. Chem. Soc. 2009, 131, 9311-9320
17. Tannock, I. F.; Rotin, D. Acid pH in Tumors and Its Potential for Therapeutic Exploitation Cancer Res. 1989, 49, 4373-4384
18. Vaupel, P.; Kallinowski, F.; Okunieff, P. Blood Flow, Oxygen and Nutrient Supply, and Metabolic Microenvironment of Human Tumors: A Review Cancer Res. 1989, 49, 6449-6465
19. Casey, J. R.; Grinstein, S.; Orlowski, J. Sensors and Regulators of Intracellular pH Nat. Rev. Mol. Cell Biol 2010, 11, 50-61
20. Haran, G.; Cohen, R.; Bar, L. K.; Barenholz, Y. Transmembrane Ammonium Sulfate Gradients in Liposomes Produce Efficient and Stable Entrapment of Amphipathic Weak Bases Biochim. Biophys. Acta 1993, 1151, 201-215
21. Ma, Q.; Remsen, E. E.; Kowalewski, T.; Wooley, K. L. Two-Dimensional, Shell-Cross-Linked Nanoparticle Arrays J. Am. Chem. Soc. 2001, 123, 4627-4628
22. Li, S.-D.; Huang, L. Pharmacokinetics and Biodistribution of Nanoparticles Mol. Pharmaceutics 2008, 5, 496-504
23. Vonarbourg, A.; Passirani, C.; Saulnier, P.; Benoit, J.-P. Parameters Influencing the Stealthiness of Colloidal Drug Delivery Systems Biomaterials 2006, 27, 4356-4373
24. Sun, G.; Hagooly, A.; Xu, J.; Nystrom, A. M.; Li, Z.; Rossin, R.; Moore, D. A.; Wooley, K. L.; Welch, M. J. Facile, Efficient Approach To Accomplish Tunable Chemistries and Variable Biodistributions for Shell Cross-Linked Nanoparticles Biomacromolecules 2008, 9, 1997-2006
25. Chong, C. S.; Colbow, K. Light Scattering and Turbidity Measurements on Lipid Vesicles Biochim. Biophys. Acta 1976, 436, 260-282
26. Schurtenberger, P.; Hauser, H. Characterization of the Size Distribution of Unilamellar Vesicles by Gel Filtration, Quasi-Elastic Light Scattering and Electron Microscopy Biochim. Biophys. Acta 1984, 778, 470-480
27. Silvius, J. R.; Leventis, R. Spontaneous Interbilayer Transfer of Phospholipids: Dependence of Acyl Chain Composition Biochemistry 1993, 32, 13318-13326
28. Barltrop, J. A.; Owen, T. C.; Cory, A. H.; Cory, J. G. 5-(3-Carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl) tetrazolium, Inner Salt (MTS) and Related Analogs of 3-(4,5-Dimethylthiazolyl)- 2,5-diphenyltetrazolium Bromide (MTT) Reducing to Purple Water-Soluble Formazans as Cell-Viability Indicators Bioorg. Med. Chem. Lett. 1991, 1, 611-614
29. Chen, H.; MacDonald, R. C.; Li, S.; Krett, N. L.; Rosen, S. T.; OHalloran, T. V. Lipid Encapsulation of Arsenic Trioxide Attenuates Cytotoxicity and Allows for Controlled Anticancer Drug Release J. Am. Chem. Soc. 2006, 128, 13348-13349
30. Moyano, J. V.; Evans, J. R.; Chen, F.; Lu, M.; Werner, M. E.; Yehiely, F.; Diaz, L. K.; Turbin, D.; Karaca, G.; Wiley, E.; Nielsen, T. O.; Perou, C. M.; Cryns, V. L. Ab-Crystallin Is a Novel Oncoprotein That Predicts Poor Clinical Outcome in Breast Cancer J. Clin. Invest. 2006, 116, 261-270
31. Neve, R. M.; Chin, K.; Fridlyand, J.; Yeh, J.; Baehner, F. L.; Fevr, T.; Clark, L.; Bayani, N.; Coppe, J.-P.; Tong, F.; Speed, T.; Spellman, P. T.; DeVries, S.; Lapuk, A.; Wang, N. J.; Kuo, W.-L.; Stilwell, J. L.; Pinkel, D.; Albertson, D. G.; Waldman, F. M.; McCormick, F.; Dickson, R. B.; Johnson, M. D.; Lippman, M.; Ethier, S.; Gazdar, A.; Gray, J. W. A Collection of Breast Cancer Cell Lines for the Study of Functionally Distinct Cancer Subtypes Cancer Cell 2006, 10, 515-527
32. Cleator, S.; Heller, W.; Coombes, R. C. Triple-Negative Breast Cancer: Therapeutic Options Lancet Oncol. 2007, 8, 235-244
33. Yehiely, F.; Moyano, J. V.; Evans, J. R.; Nielsen, T. O.; Cryns, V. L. Deconstructing the Molecular Portrait of Basal-like Breast Cancer Trends Mol. Med. 2006, 12, 537-544
34. Shaner, N. C.; Campbell, R. E.; Steinbach, P. A.; Giepmans, B. N. G.; Palmer, A. E.; Tsien, R. Y. Improved Monomeric Red, Orange and Yellow Fluorescent Proteins Derived from Discosoma Sp. Red Fluorescent Protein Nat. Biotechnol. 2004, 22, 1567-1572
35. Wang, L.; Jackson, W. C.; Steinbach, P. A.; Tsien, R. Y. Evolution of New Nonantibody Proteins via Iterative Somatic Hypermutation Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 16745-16749
36. Hoffman, R. M. The Multiple Uses of Fluorescent Proteins To Visualize Cancer In Vivo Nat. Rev. Cancer 2005, 5, 796-806
37. All animal experiments were performed in accordance with protocols approved by the Northwestern University Animal Care and Use Committee.
38. Littell, R. C.; Henry, P. R.; Ammerman, C. B. Statistical Analysis of Repeated Measures Data Using SAS Procedures J. Anim. Sci. 1998, 76, 1216-1231
39. Chen, H.; Pazicni, S.; Krett, N. L.; Ahn, R. W.; Penner-Hahn, J. E.; Rosen, S. T.; OHalloran, T. V. Coencapsulation of Arsenic- and Platinum-Based Drugs for Targeted Cancer Treatment Angew. Chem., Int. Ed. 2009, 48, 9295-9299
40. Chaires, J. B.; Dattagupta, N.; Crothers, D. M. Selfassociation of Daunomycin Biochemistry 1982, 21, 3927-3932